vs

Side-by-side financial comparison of Broadway Financial Corp (BYFC) and Cytosorbents Corp (CTSO). Click either name above to swap in a different company.

Broadway Financial Corp is the larger business by last-quarter revenue ($9.4M vs $9.2M, roughly 1.0× Cytosorbents Corp). Broadway Financial Corp runs the higher net margin — 1934.0% vs -59.5%, a 1993.5% gap on every dollar of revenue. On growth, Broadway Financial Corp posted the faster year-over-year revenue change (10.1% vs 0.9%). Broadway Financial Corp produced more free cash flow last quarter ($-13.0K vs $-4.9M). Over the past eight quarters, Broadway Financial Corp's revenue compounded faster (9.7% CAGR vs 1.3%).

Virtu Financial, Inc. is an American high-frequency trading company. The company went public on the Nasdaq in 2015.

CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.

BYFC vs CTSO — Head-to-Head

Bigger by revenue
BYFC
BYFC
1.0× larger
BYFC
$9.4M
$9.2M
CTSO
Growing faster (revenue YoY)
BYFC
BYFC
+9.2% gap
BYFC
10.1%
0.9%
CTSO
Higher net margin
BYFC
BYFC
1993.5% more per $
BYFC
1934.0%
-59.5%
CTSO
More free cash flow
BYFC
BYFC
$4.9M more FCF
BYFC
$-13.0K
$-4.9M
CTSO
Faster 2-yr revenue CAGR
BYFC
BYFC
Annualised
BYFC
9.7%
1.3%
CTSO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BYFC
BYFC
CTSO
CTSO
Revenue
$9.4M
$9.2M
Net Profit
$1.0M
$-5.5M
Gross Margin
73.7%
Operating Margin
-47.5%
Net Margin
1934.0%
-59.5%
Revenue YoY
10.1%
0.9%
Net Profit YoY
-21.8%
27.4%
EPS (diluted)
$0.02
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BYFC
BYFC
CTSO
CTSO
Q4 25
$9.4M
$9.2M
Q3 25
$9.0M
$9.5M
Q2 25
$8.1M
$9.6M
Q1 25
$8.3M
$8.7M
Q4 24
$8.6M
$9.2M
Q3 24
$8.7M
$8.6M
Q2 24
$8.2M
$8.8M
Q1 24
$7.8M
$9.0M
Net Profit
BYFC
BYFC
CTSO
CTSO
Q4 25
$1.0M
$-5.5M
Q3 25
$-23.9M
$-3.2M
Q2 25
$752.0K
$1.9M
Q1 25
$-2.7M
$-1.5M
Q4 24
$1.3M
$-7.6M
Q3 24
$516.0K
$-2.8M
Q2 24
$256.0K
$-4.3M
Q1 24
$-154.0K
$-6.1M
Gross Margin
BYFC
BYFC
CTSO
CTSO
Q4 25
73.7%
Q3 25
70.3%
Q2 25
70.9%
Q1 25
71.1%
Q4 24
68.4%
Q3 24
61.0%
Q2 24
73.5%
Q1 24
76.5%
Operating Margin
BYFC
BYFC
CTSO
CTSO
Q4 25
-47.5%
Q3 25
-256.2%
-30.2%
Q2 25
12.8%
-37.6%
Q1 25
-45.3%
-44.5%
Q4 24
21.7%
-37.1%
Q3 24
8.5%
-56.1%
Q2 24
4.8%
-40.4%
Q1 24
-2.9%
-51.8%
Net Margin
BYFC
BYFC
CTSO
CTSO
Q4 25
1934.0%
-59.5%
Q3 25
-264.2%
-33.4%
Q2 25
9.3%
20.2%
Q1 25
-32.3%
-16.9%
Q4 24
15.3%
-82.7%
Q3 24
5.9%
-32.1%
Q2 24
3.1%
-48.6%
Q1 24
-2.0%
-67.7%
EPS (diluted)
BYFC
BYFC
CTSO
CTSO
Q4 25
$0.02
$-0.09
Q3 25
$-2.86
$-0.05
Q2 25
$0.00
$0.03
Q1 25
$-0.39
$-0.02
Q4 24
$0.07
$-0.14
Q3 24
$-0.03
$-0.05
Q2 24
$0.02
$-0.08
Q1 24
$-0.02
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BYFC
BYFC
CTSO
CTSO
Cash + ST InvestmentsLiquidity on hand
$10.5M
$6.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$262.8M
$5.9M
Total Assets
$1.3B
$44.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BYFC
BYFC
CTSO
CTSO
Q4 25
$10.5M
$6.2M
Q3 25
$19.7M
$7.5M
Q2 25
$29.5M
$10.2M
Q1 25
$15.8M
$11.6M
Q4 24
$61.4M
$3.3M
Q3 24
$97.1M
$5.7M
Q2 24
$89.8M
$8.5M
Q1 24
$67.1M
$8.6M
Total Debt
BYFC
BYFC
CTSO
CTSO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$13.8M
Q2 24
$13.7M
Q1 24
$4.4M
Stockholders' Equity
BYFC
BYFC
CTSO
CTSO
Q4 25
$262.8M
$5.9M
Q3 25
$261.7M
$9.0M
Q2 25
$284.7M
$11.6M
Q1 25
$283.6M
$14.5M
Q4 24
$285.0M
$11.1M
Q3 24
$286.2M
$13.4M
Q2 24
$282.1M
$17.4M
Q1 24
$281.1M
$19.6M
Total Assets
BYFC
BYFC
CTSO
CTSO
Q4 25
$1.3B
$44.2M
Q3 25
$1.3B
$45.8M
Q2 25
$1.2B
$48.0M
Q1 25
$1.3B
$50.8M
Q4 24
$1.3B
$47.4M
Q3 24
$1.4B
$47.8M
Q2 24
$1.4B
$53.4M
Q1 24
$1.4B
$47.1M
Debt / Equity
BYFC
BYFC
CTSO
CTSO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.03×
Q2 24
0.78×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BYFC
BYFC
CTSO
CTSO
Operating Cash FlowLast quarter
$230.0K
$-4.8M
Free Cash FlowOCF − Capex
$-13.0K
$-4.9M
FCF MarginFCF / Revenue
-0.1%
-53.4%
Capex IntensityCapex / Revenue
2.6%
1.2%
Cash ConversionOCF / Net Profit
0.22×
TTM Free Cash FlowTrailing 4 quarters
$2.3M
$-12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BYFC
BYFC
CTSO
CTSO
Q4 25
$230.0K
$-4.8M
Q3 25
$3.8M
$-2.6M
Q2 25
$3.0M
$-1.5M
Q1 25
$-4.3M
$-3.5M
Q4 24
$1.4M
$-2.3M
Q3 24
$6.1M
$-2.5M
Q2 24
$9.8M
$-4.8M
Q1 24
$-11.7M
$-4.8M
Free Cash Flow
BYFC
BYFC
CTSO
CTSO
Q4 25
$-13.0K
$-4.9M
Q3 25
$3.7M
$-2.6M
Q2 25
$3.0M
$-1.5M
Q1 25
$-4.4M
$-3.5M
Q4 24
$1.3M
$-2.4M
Q3 24
$6.1M
$-2.6M
Q2 24
$9.7M
$-4.8M
Q1 24
$-11.7M
$-4.9M
FCF Margin
BYFC
BYFC
CTSO
CTSO
Q4 25
-0.1%
-53.4%
Q3 25
41.1%
-27.3%
Q2 25
37.0%
-16.1%
Q1 25
-52.4%
-39.7%
Q4 24
14.7%
-26.3%
Q3 24
69.6%
-30.4%
Q2 24
118.9%
-54.4%
Q1 24
-149.7%
-54.2%
Capex Intensity
BYFC
BYFC
CTSO
CTSO
Q4 25
2.6%
1.2%
Q3 25
1.2%
0.2%
Q2 25
0.2%
0.4%
Q1 25
0.2%
0.0%
Q4 24
1.6%
0.8%
Q3 24
0.3%
1.8%
Q2 24
0.5%
0.2%
Q1 24
0.7%
0.5%
Cash Conversion
BYFC
BYFC
CTSO
CTSO
Q4 25
0.22×
Q3 25
Q2 25
4.00×
-0.78×
Q1 25
Q4 24
1.06×
Q3 24
11.85×
Q2 24
38.21×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BYFC
BYFC

Segment breakdown not available.

CTSO
CTSO

Direct$5.1M55%
Distributors And Strategic Partners$4.2M45%

Related Comparisons